Annual Shareholders Equity
$1.04 B
-$31.10 M-2.89%
December 31, 2023
Summary
- As of February 7, 2025, VCYT annual stockholders equity is $1.04 billion, with the most recent change of -$31.10 million (-2.89%) on December 31, 2023.
- During the last 3 years, VCYT annual shareholders equity has risen by +$622.87 million (+147.87%).
- VCYT annual shareholders equity is now -4.78% below its all-time high of $1.10 billion, reached on December 31, 2021.
Performance
VCYT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.18 B
+$43.52 M+3.84%
September 30, 2024
Summary
- As of February 7, 2025, VCYT quarterly stockholders equity is $1.18 billion, with the most recent change of +$43.52 million (+3.84%) on September 30, 2024.
- Over the past year, VCYT quarterly shareholders equity has increased by +$131.94 million (+12.64%).
- VCYT quarterly shareholders equity is now at all-time high.
Performance
VCYT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VCYT Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.9% | +12.6% |
3 y3 years | +147.9% | +6.2% |
5 y5 years | +1209.1% | +409.1% |
VCYT Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -4.8% | at low | at high | +12.6% |
5 y | 5-year | -4.8% | +336.0% | at high | +420.0% |
alltime | all time | -4.8% | >+9999.0% | at high | >+9999.0% |
Veracyte Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.18 B(+3.8%) |
Jun 2024 | - | $1.13 B(+1.2%) |
Mar 2024 | - | $1.12 B(+7.1%) |
Dec 2023 | $1.04 B(-2.9%) | $1.04 B(-0.9%) |
Sep 2023 | - | $1.05 B(-2.6%) |
Jun 2023 | - | $1.08 B(+0.1%) |
Mar 2023 | - | $1.08 B(+0.6%) |
Dec 2022 | $1.08 B(-1.9%) | $1.08 B(+2.6%) |
Sep 2022 | - | $1.05 B(-1.5%) |
Jun 2022 | - | $1.06 B(-1.9%) |
Mar 2022 | - | $1.09 B(-1.0%) |
Dec 2021 | $1.10 B(+160.3%) | $1.10 B(-1.0%) |
Sep 2021 | - | $1.11 B(+14.0%) |
Jun 2021 | - | $971.18 M(-0.3%) |
Mar 2021 | - | $974.23 M(+131.3%) |
Dec 2020 | $421.23 M(+75.9%) | $421.23 M(-0.4%) |
Sep 2020 | - | $422.73 M(+86.9%) |
Jun 2020 | - | $226.15 M(-1.9%) |
Mar 2020 | - | $230.42 M(-3.8%) |
Dec 2019 | $239.46 M(+200.2%) | $239.46 M(+3.6%) |
Sep 2019 | - | $231.02 M(+3.0%) |
Jun 2019 | - | $224.24 M(+167.7%) |
Mar 2019 | - | $83.77 M(+5.0%) |
Dec 2018 | $79.75 M | $79.75 M(+0.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $79.42 M(+207.7%) |
Jun 2018 | - | $25.81 M(-14.0%) |
Mar 2018 | - | $30.01 M(-19.4%) |
Dec 2017 | $37.23 M(-37.5%) | $37.23 M(-13.1%) |
Sep 2017 | - | $42.82 M(-10.5%) |
Jun 2017 | - | $47.84 M(-10.3%) |
Mar 2017 | - | $53.35 M(-10.5%) |
Dec 2016 | $59.58 M(+16.3%) | $59.58 M(+98.6%) |
Sep 2016 | - | $30.00 M(-11.1%) |
Jun 2016 | - | $33.75 M(-22.1%) |
Mar 2016 | - | $43.31 M(-15.5%) |
Dec 2015 | $51.25 M(+23.9%) | $51.25 M(-11.3%) |
Sep 2015 | - | $57.81 M(-11.2%) |
Jun 2015 | - | $65.09 M(+85.5%) |
Mar 2015 | - | $35.08 M(-15.2%) |
Dec 2014 | $41.37 M(-26.7%) | $41.37 M(-14.3%) |
Sep 2014 | - | $48.28 M(+7.2%) |
Jun 2014 | - | $45.02 M(-10.5%) |
Mar 2014 | - | $50.29 M(-10.9%) |
Dec 2013 | $56.44 M(+1051.7%) | $56.44 M(+2206.6%) |
Sep 2013 | - | $2.45 M(-70.9%) |
Jun 2013 | - | $8.41 M(+71.6%) |
Dec 2012 | $4.90 M(-42.5%) | $4.90 M |
Dec 2011 | $8.53 M | - |
FAQ
- What is Veracyte annual stockholders equity?
- What is the all time high annual shareholders equity for Veracyte?
- What is Veracyte annual shareholders equity year-on-year change?
- What is Veracyte quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Veracyte?
- What is Veracyte quarterly shareholders equity year-on-year change?
What is Veracyte annual stockholders equity?
The current annual shareholders equity of VCYT is $1.04 B
What is the all time high annual shareholders equity for Veracyte?
Veracyte all-time high annual stockholders equity is $1.10 B
What is Veracyte annual shareholders equity year-on-year change?
Over the past year, VCYT annual stockholders equity has changed by -$31.10 M (-2.89%)
What is Veracyte quarterly stockholders equity?
The current quarterly shareholders equity of VCYT is $1.18 B
What is the all time high quarterly shareholders equity for Veracyte?
Veracyte all-time high quarterly stockholders equity is $1.18 B
What is Veracyte quarterly shareholders equity year-on-year change?
Over the past year, VCYT quarterly stockholders equity has changed by +$131.94 M (+12.64%)